Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Innovatex is a medical device company specializing in ophthalmic therapeutic devices. Founded in 2006, the company is best known for developing the Tear Duct Occluder, an FDA-approved, prescription-only nasolacrimal compression device designed to temporarily occlude the tear ducts in adult patients. The device helps improve the absorption of glaucoma and dry eye eyedrops while preventing systemic side effects by blocking the drainage of medication into the throat. Innovatex operates out of Weston, Massachusetts, and distributes its products globally.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Innovatex.